PLPL — Plandai Biotechnology Balance Sheet
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
- $4.49m
- $19.02m
- $0.30m
Annual balance sheet for Plandai Biotechnology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
C2012 June 30th | 2013 June 30th | R2014 June 30th | C2015 June 30th | 2016 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.005 | 0.499 | 0.156 | 0.034 | 0.013 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | 0.014 | 0.434 | 0.017 | 0.041 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.005 | 0.519 | 0.688 | 0.327 | 0.185 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.216 | 7.92 | 8.39 | 8.01 | 6.08 |
| Other Long Term Assets | |||||
| Total Assets | 6.06 | 8.84 | 9.21 | 8.5 | 6.45 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.1 | 0.904 | 3.25 | 15.2 | 16.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.86 | 11.5 | 12 | 15 | 16.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.806 | -2.63 | -2.78 | -6.54 | -9.8 |
| Total Liabilities & Shareholders' Equity | 6.06 | 8.84 | 9.21 | 8.5 | 6.45 |
| Total Common Shares Outstanding |